Compare MSGM & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MSGM | HOWL |
|---|---|---|
| Founded | 2018 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.0M | 17.9M |
| IPO Year | 2020 | 2021 |
| Metric | MSGM | HOWL |
|---|---|---|
| Price | $4.49 | $0.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 34.7K | ★ 555.9K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 252.13 | 18.40 |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $741,000.00 | N/A |
| Revenue This Year | $69.73 | N/A |
| Revenue Next Year | $146.81 | N/A |
| P/E Ratio | $74.67 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.11 | $0.27 |
| 52 Week High | $5.78 | $2.23 |
| Indicator | MSGM | HOWL |
|---|---|---|
| Relative Strength Index (RSI) | 49.95 | 52.04 |
| Support Level | $3.71 | $0.40 |
| Resistance Level | $4.73 | $0.43 |
| Average True Range (ATR) | 0.40 | 0.05 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 69.75 | 32.73 |
Motorsport Games Inc is a racing game developer, publisher, and esports ecosystem provider of official motorsport racing series, including games based on the 24 Hours of Le Mans endurance race (Le Mans) and the associated FIA World Endurance Championship (the WEC). Its portfolio also includes the KartKraft karting simulation game, as well as Studio 397 B.V. (Studio397) and their rFactor 2 realistic racing simulator technology and platform. The games are developed and published for personal computers (PCs) through various digital channels, including full-game and downloadable content (DLC). Additionally, Motorsport Games organizes esports tournaments, competitions, and events. Its reportable segments are: Gaming, which generates the maximum revenue, and Esports.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.